{
  "docId": "019de511-116c-769a-af30-00a56112ffbd",
  "docSlug": "6dbbbde9942752c16f9f4678dff28ed3",
  "documentTitle": "Nyxoah | IPO Presentation Deck | 34 slides",
  "authorId": "nyxoah",
  "authorName": "Nyxoah",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investment_bank",
  "sourceTypeLabel": "Investment bank",
  "presentationDate": "2021-06-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7794254,
  "pageNumber": 23,
  "pageCount": 34,
  "prevPage": 22,
  "nextPage": 24,
  "slideType": "traction",
  "function": "show_traction",
  "density": "dense",
  "nDataPoints": 8,
  "notes": "The slide uses a map-based visualization to show the geographic distribution of clinical trial sites.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de511-116c-769a-af30-00a56112ffbd/23",
  "deckHref": "/decks/019de511-116c-769a-af30-00a56112ffbd",
  "deckJsonHref": "/decks/019de511-116c-769a-af30-00a56112ffbd.json",
  "deckAnchorHref": "/decks/019de511-116c-769a-af30-00a56112ffbd#slide-23",
  "components": [
    {
      "bbox": {
        "h": 0.75,
        "w": 0.35,
        "x": 0.62,
        "y": 0.15
      },
      "kind": "image",
      "text": "Geographic distribution of trial sites in US, Australia, and Belgium/Germany",
      "attrs": null,
      "subkind": "map",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2bee3538-bb24-4e55-8647-f9a01ed1a748",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.53,
        "x": 0.04,
        "y": 0.36
      },
      "kind": "list",
      "text": "Safety and Performance: Incidence of device-related serious adverse events at 12 months; Co-primary effectiveness endpoints based on AHI and ODI.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3c1ea78b-42de-4256-990b-59981d5cb9dd",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.53,
        "x": 0.04,
        "y": 0.55
      },
      "kind": "list",
      "text": "Status: FDA approved June 2020; 18 US sites (16 active); 7 International sites (5 active); Mix of academic and private practices.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4665f414-ca3d-450c-95a8-240442d75e0d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.53,
        "x": 0.04,
        "y": 0.18
      },
      "kind": "list",
      "text": "Population and key inclusion criteria: 22 < Age < 75, BMI <= 32 kg/m2, Failed/refused PAP, AHI 15-65, Target: 134 patients implanted",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "48312d85-ae81-41e4-a18a-1856caaa14ca",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.3,
        "x": 0.03,
        "y": 0.03
      },
      "kind": "title",
      "text": "DREAM trial – IDE Pivotal Trial",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3a0e4405-fe13-4cfe-bf22-9fb2e83afcf5",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "List presentation",
      "slug": "list-presentation",
      "agent": null,
      "layer": "slide",
      "matchId": "b30f238d-8dae-4adf-b39a-845e3b18af5d",
      "evidence": "list/bullet: Safety and Performance: Incidence of device-related serious adverse events at 12 months; Co-primary effectiveness endpoints based on AHI and ODI",
      "confidence": 0.7
    }
  ],
  "frameworks": [
    {
      "name": "map-spatial",
      "slug": null,
      "matchId": "8cc865e6-1534-455b-88d5-27cb61ba15a2",
      "evidence": "Use of geographic maps to visualize clinical trial site distribution.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}